Academic Journals Database
Disseminating quality controlled scientific knowledge

Nonsteroidal Anti-Inflammatory Drugs (NSAIDs): Progress in Small Molecule Drug Development

ADD TO MY LIST
 
Author(s): Praveen P. N. Rao | Saad N. Kabir | Tarek Mohamed

Journal: Pharmaceuticals
ISSN 1424-8247

Volume: 3;
Issue: 5;
Start page: 1530;
Date: 2010;
Original page

Keywords: Small molecules | NSAIDs | Lp-PLA2 | mPGES-1 | TNF-α

ABSTRACT
Ever since the discovery of aspirin, small molecule therapeutics have been widely prescribed to treat inflammation and pain. Aspirin and several small molecule NSAIDs are known to inhibit the enzymes cyclooxygenase-1 (COX-1) and -2 (COX-2). Despite the success of NSAIDs to treat inflammatory disorders, the development of a clinically useful small molecule NSAIDs with decreased side effect profiles is an ongoing effort. The recent discovery and development of selective COX-2 inhibitors was a step toward this direction. Emerging trends are represented by the progress in the development of hybrid agents such as nitric oxide donor-NSAIDs (NO-NSAIDs) and dual COX/lipoxygenase (LOX) inhibitors. This review focuses on the recent advances in the rational design of small molecule NSAIDs in therapy.
Why do you need a reservation system?      Affiliate Program